SCHEMBL29941024

SCHEMBL29941024

C1CCC2CCCC(CCCCCN3CCCC(CC1)C3)C2

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3626856 0.91 CHRM5 (0.33) CYP2D6MEN1KMT2ALMNA
SCHEMBL4175185 0.91 CHRM5 (0.33) CYP2D6MEN1KMT2ALMNA
SCHEMBL13835555 0.88 CYP2D6 (0.34) CYP2D6MEN1KMT2ALMNA
SCHEMBL7593004 0.88 CYP2D6 (0.32) CYP2D6MEN1KMT2ALMNA
SCHEMBL3399160 0.85
SCHEMBL13836053 0.85 CYP2D6 (0.33) CYP2D6MEN1KMT2ALMNA
SCHEMBL24409361 0.83
SCHEMBL28564 0.83
SCHEMBL27729 0.83
Iodide SCHEMBL3654797 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed